AAAAAA
Results: 51-75/1162
Authors:
Bartels, PH
Montironi, RM
Bostwick, D
Marshall, J
Thompson, D
Bartels, HG
Kelley, D
Citation: Ph. Bartels et al., Karyometry of secretory cell nuclei in high-grade PIN lesions, PROSTATE, 48(3), 2001, pp. 144-155
Authors:
Stachon, A
Scluter, T
Koller, M
Weisser, H
Krieg, M
Citation: A. Stachon et al., Primary culture of microvascular endothelial cells from human benign prostatic hyperplasia, PROSTATE, 48(3), 2001, pp. 156-164
Authors:
Diss, JKJ
Archer, SN
Hirano, J
Fraser, SP
Djamgoz, MBA
Citation: Jkj. Diss et al., Expression profiles of voltage-gated Na+ channel alpha-subunit genes in rat and human prostate cancer cell lines, PROSTATE, 48(3), 2001, pp. 165-178
Authors:
Valencia, S
Hernandez-Angeles, A
Soria-Jasso, LE
Arias-Montano, JA
Citation: S. Valencia et al., Histamine H-1 receptor activation inhibits the proliferation of human prostatic adenocarcinoma DU-145 cells, PROSTATE, 48(3), 2001, pp. 179-187
Authors:
Rekasi, Z
Schally, AV
Plonowski, A
Czompoly, T
Csernus, B
Varga, JL
Citation: Z. Rekasi et al., Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormoneand vasoactive intestinal peptide, PROSTATE, 48(3), 2001, pp. 188-199
Authors:
Miller, EA
Stanford, JL
Hsu, L
Noonan, E
Ostrander, EA
Citation: Ea. Miller et al., Polymorphic repeats in the androgen receptor gene in high-risk sibships, PROSTATE, 48(3), 2001, pp. 200-205
Authors:
Stratton, MS
Sirvent, H
Udayakumar, TS
Nagle, RB
Bowden, GT
Citation: Ms. Stratton et al., Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines, PROSTATE, 48(3), 2001, pp. 206-209
Authors:
Leav, I
Schelling, JH
Adams, JY
Merk, FB
Alroy, J
Citation: I. Leav et al., Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth;; and the ductal origin ofcarcinoma (vol 47, pg 149, 2000), PROSTATE, 48(3), 2001, pp. 210-224
Authors:
Gao, J
Isaacs, JT
Citation: J. Gao et Jt. Isaacs, Mixed lineage kinase (MLK) family members are not involved in androgen regulation of prostatic proliferation or apoptosis, PROSTATE, 48(2), 2001, pp. 67-70
Authors:
Keledjian, K
Borkowski, A
Kim, G
Isaacs, JT
Jacobs, SC
Kyprianou, N
Citation: K. Keledjian et al., Reduction of human prostate tumor vascularity by the alpha 1-adrenoceptor antagonist terazosin, PROSTATE, 48(2), 2001, pp. 71-78
Authors:
Schmelz, M
Cress, AE
Barrera, J
McDaniel, KM
Davis, TL
Fuchs, L
Dalkin, BL
Nagle, RB
Citation: M. Schmelz et al., PEAZ-1: A new human prostate neoplastic epithelial cell line, PROSTATE, 48(2), 2001, pp. 79-92
Authors:
Chen, LM
Hodge, GB
Guarda, LA
Welch, JL
Greenberg, NM
Chai, KX
Citation: Lm. Chen et al., Down-regulation of prostasin serine protease: A potential invasion suppressor in prostate cancer, PROSTATE, 48(2), 2001, pp. 93-103
Authors:
Goossens, K
Deboel, L
Swinnen, JV
De Gendt, K
Rombauts, W
Verhoeven, G
Citation: K. Goossens et al., Effects and characterization of paracrine factors produced by human prostate stromal cells in bioassays using rat sertoli cells, LNCaP tumor cells, and cultured prostate epithelial cells, PROSTATE, 48(2), 2001, pp. 104-117
Authors:
Tavani, A
Gallus, S
Franceschi, S
La Vecchia, C
Citation: A. Tavani et al., Calcium, dairy products, and the risk of prostate cancer, PROSTATE, 48(2), 2001, pp. 118-121
Authors:
Denmeade, SR
Lovgren, J
Khan, SR
Lilja, H
Isaacs, JT
Citation: Sr. Denmeade et al., Activation of latent protease function of Pro-HK2, but not Pro-PSA, involves autoprocessing, PROSTATE, 48(2), 2001, pp. 122-126
Authors:
Denmeade, SR
Sokoll, LJ
Chan, DW
Khan, SR
Isaacs, JT
Citation: Sr. Denmeade et al., Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostatecancer xenograft models, PROSTATE, 48(1), 2001, pp. 1-6
Authors:
Xing, NZ
Qian, JQ
Bostwick, D
Bergstralh, E
Young, CYF
Citation: Nz. Xing et al., Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin, PROSTATE, 48(1), 2001, pp. 7-15
Authors:
Malkowicz, SB
McKenna, WG
Vaughn, DJ
Wan, XS
Propert, KJ
Rockwell, K
Marks, SHF
Wein, AJ
Kennedy, AR
Citation: Sb. Malkowicz et al., Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia, PROSTATE, 48(1), 2001, pp. 16-28
Authors:
Collette, L
Studer, UE
Schroder, FH
Denis, LJ
Sylvester, RJ
Citation: L. Collette et al., Why phase III trials of maximal androgen blockade versus castration in M-1prostate cancer rarely show statistically significant differences, PROSTATE, 48(1), 2001, pp. 29-39
Authors:
Aikawa, K
Yokota, T
Okamura, H
Yamaguchi, O
Citation: K. Aikawa et al., Endogenous nitric oxide-mediated relaxation and nitrinergic innervation inthe rabbit prostate: The changes with aging, PROSTATE, 48(1), 2001, pp. 40-46
Authors:
Smith, PC
Keller, ET
Citation: Pc. Smith et Et. Keller, Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice, PROSTATE, 48(1), 2001, pp. 47-53
Authors:
Amadesi, S
Varani, K
Spisani, L
Daniele, C
Turini, A
Agnello, G
Zamboni, P
Borea, PA
Geppetti, P
Citation: S. Amadesi et al., Comparison of Prazosin,Terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues, PROSTATE, 47(4), 2001, pp. 231-238
Authors:
Romanov, VI
Durand, DB
Petrenko, VA
Citation: Vi. Romanov et al., Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion, PROSTATE, 47(4), 2001, pp. 239-251
Authors:
Vis, AN
Hoedemaeker, RF
Roobol, M
van der Kwast, TH
Schroder, FH
Citation: An. Vis et al., Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml), PROSTATE, 47(4), 2001, pp. 252-261
Authors:
Newcomer, LM
King, IB
Wicklund, KG
Stanford, JL
Citation: Lm. Newcomer et al., The association of fatty acids with prostate cancer risk, PROSTATE, 47(4), 2001, pp. 262-268